Found 8 matching trials
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
PHASE2The purpose of this study is to establish a prospective, single-center plat...
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
PHASE2The purpose of this study is to establish a prospective, multi-center platf...
Location
Breast cancer institute of Fudan University Cancer Hospital
The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis
PHASE2The goal of this clinical trial is to learn if Trastuzumab Rezetecan (SHR-A...
Location
Cancer Hospital, Chinese Academy of Medical Sciences
A Study of HRS-4508 in Combination With Other Anti-tumor Therapy for Solid Tumor
PHASE1The study is being conducted to evaluate the efficacy, safety, and ORR of H...
Location
Cancer Hospital Chinese Academy of Medical Science
A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer
PHASE2To evaluate the safety, tolerability and efficacy of SHR-A1811 in combinati...
Location
Jiangsu Provincial People's Hospital
Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging
PHASE2This study evaluates HER2-PET/CT-guided dynamic optimization of neoadjuvant...
Location
Multiple Locations
This Study Aims to Optimize Neoadjuvant Therapy for HER2-positive Breast Cancer by Implementing a Dynamic Monitoring-guided Treatment Strategy.
PHASE2This study aims to optimize neoadjuvant therapy for HER2-positive breast ca...
Location
Multiple Locations
SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC
PHASE2The goal of this clinical trial is to evaluate the efficacy and safety of S...
Location
Henan Cancer Hospital